Is Z.AI (SEHK:2513) Undervalued Following Its Half Year 2026 Results?

Z.AI (SEHK:2513) reported half year 2026 results, with sales of CNY 953.89 million and a net loss of CNY 2,071.33 million, a key update that quickly fed into investor sentiment.

At a latest share price of HK$1,075.0, Z.AI has recorded a substantial year-to-date share price return of about 7x. However, the 90‑day share price return is down 17.12%, which indicates that while longer-term momentum has been strong, more recent gains have moderated.

Spot opportunities across AI by reviewing the 71 profitable AI stocks that aren't just burning cash, which pairs revenue traction with more disciplined bottom lines than Z.AI today.

After a surge of about 7x this year and a pullback over the past quarter, Z.AI now splits opinion on whether the big move is already in the rear view mirror or if the current valuation still leaves room on the table.

DCF view says Z.AI could be far ahead of its current price

According to the SWS DCF model, Z.AI has an estimated fair value of HK$2,990.3 per share, compared with the latest close of HK$1,075. This suggests the market price is materially below the modelled future cash flow value.

The SWS DCF model projects Z.AI's future cash flows and then discounts them back to today using a required rate of return. That process aims to translate long term revenue and profit expectations into a single present value number that can be compared with the current share price.

For a company like Z.AI that is currently loss making but has analyst forecasts for high revenue growth and a move into profitability over the next three years, a DCF framework focuses attention on how long it may take for cash generation to catch up with the valuation. It also makes clear that small shifts in growth or margin assumptions can have a large impact on the implied fair value.

Look into how the SWS DCF model arrives at its fair value.

Result: DCF Fair value of HK$2,990.3 (UNDERVALUED)

However, Z.AI still carries clear risks, including its sizeable CN¥2,945.988 million net loss and the recent 17.12% share price decline over 90 days.

Find out about the key risks to this Z.AI narrative.

Another view on Z.AI’s valuation from the market price

While the SWS DCF model points to a large gap between fair value and the current HK$1,075 share price, the market is sending a more cautious signal. Z.AI trades at a P/B of 97x, far above both Hong Kong software peers at 11.7x and the wider Hong Kong Software industry at 1.6x.

This kind of premium P/B ratio suggests investors are already paying a high price relative to the company’s book value. The key question is whether Z.AI can eventually justify that premium with the business performance implied in the SWS DCF model, or if expectations have run too far ahead.

See what the numbers say about this price — find out in our valuation breakdown.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Z.AI for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 262 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Z.AI drawing mixed reactions from its recent moves and valuation signals, it makes sense to move quickly and review the data directly yourself. To see both the potential upsides and the issues investors are debating, start with the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Z.AI?

If you only focus on Z.AI, you could miss other stocks that fit your style better, so use the Simply Wall St Screener to widen your field of ideas.

• Target stability and resilience by checking the 305 resilient stocks with low risk scores that may hold up better when conditions get tougher.
• Hunt for quality at sensible prices by scanning the 262 high quality undervalued stocks that combine solid fundamentals with more grounded valuations.
• Build a shortlist of financially healthy companies by reviewing the list of solid balance sheet and fundamentals (439 results) that focus on robust balance sheets and fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com